Drug
Bibw 2948 BS
Bibw 2948 BS: highest development phase Phase 2, developed by Boehringer Ingelheim. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Boehringer Ingelheim
Trials
| Drug | Phase | Indication |
|---|---|---|
| BIBW 2948 BS NCT00726479 | Phase 2 | Pulmonary Disease, Chronic Obstructive |
Latest
No recent events.
Follow Bibw 2948 BS on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.